ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,292.80
      0.00%
      Dow Jones
      40,415.44
      0.32%
      Brent Oil
      81.725
      0.26%
      Bitcoin
      66,369.00
      -1.83%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ritter Pharmaceuticals Inc (RTTR)

      7. Ritter Pharmaceuticals Inc (RTTR) Financials

      Ritter Pharmaceuticals Inc

      Ritter Pharmaceuticals Inc (RTTR)

      NASDAQ
      0.448
      0.00
      (0.00%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Ritter Pharmaceuticals Inc Financial Summary

      The current RTTR market cap is 2.32M. The company's latest EPS is USD -2.5897 and P/E is -0.17.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.61M1.63M000
      Operating Income -3.69M-3.55M-1.15M-2.27M-1.42M
      Net Income -3.85M-3.46M-3.66M-2.45M-2.03M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 02.85M5.65M4.98M0
      Operating Income -10.84M-11.9M-22.66M-22.18M-11.31M
      Net Income -10.13M-19.55M-17.9M-18.64M-13.42M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 15.91M13.15M4.32M2.03M1M
      Total Liabilities 9.71M9.84M5.96M4.14M4.53M
      Total Equity 6.2M3.31M-1.64M-2.1M-3.52M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.8M29.13M22.84M19.08M2.03M
      Total Liabilities 1.7M10.83M6.27M10.32M4.14M
      Total Equity 1.1M18.3M16.57M8.77M-2.1M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -2.63M-5.56M-4.63M-10.3M-784k
      Investing -198k-246k3.98M4.22M N/A
      Financing N/A N/A -440k-550k475k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -14.52M-10.16M-14.73M-13.25M-10.3M
      Investing 7M-64k-141k-184k4.22M
      Financing 1.41M34.05M8.43M2.91M-550k

      Stats and Ratios

      Market Cap 2.32M
      Price to Earnings Ratio -0.17
      Price to Sales Ratio 0
      Price to Cash Ratio 5.8
      Price to Book Ratio -1.11
      Dividend Yield -

      Share Statistics

      Shares Outstanding 5.18M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0 (0.64%)

      Company Info

      Company Name Ritter Pharmaceuticals Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.qualigeninc.com
      Industry pharmaceutical preparations (2834)